Related Experiment Video

Updated: Aug 18, 2026

A Melanoma Patient-Derived Xenograft Model
07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Action of interferon alpha and beta on four human melanoma cell lines in vitro

J Köpf1, C Hanson, U Delle

  • 1Department of Oncology, University of Göteborg, Sweden.

Anticancer Research
|March 1, 1996
PubMed

Insights

Melanoma cell sensitivity to Interferon-alpha (IFN-alpha) and Interferon-beta (IFN-beta) correlates with interferon gene copy number on chromosome 9. Increased interferon receptor genes on chromosome 21 did not affect sensitivity.

Area of Science:

  • Oncology
  • Genetics
  • Immunology

Background:

  • Melanoma is a significant form of skin cancer.
  • Interferons (IFNs) are cytokines with therapeutic potential in cancer treatment.
  • Understanding genetic factors influencing IFN sensitivity is crucial for effective therapy.

Purpose of the Study:

  • To investigate the relationship between specific chromosomal copy numbers and melanoma cell sensitivity to Interferon-alpha (IFN-alpha) and Interferon-beta (IFN-beta).
  • To determine the role of interferon gene dosage (chromosome 9) and interferon receptor gene dosage (chromosome 21p) in IFN response.

Main Methods:

  • Utilized four human melanoma cell lines with varying copy numbers of chromosomes 9 and 21q.
  • Employed G-banding technique, fluorescent in situ hybridization (FISH), and Polymerase Chain Reaction (PCR) for genetic analysis.
  • Assessed cellular sensitivity to IFN-alpha and IFN-beta.

Main Results:

  • Melanoma cell lines with higher copy numbers of chromosome 9 (containing interferon genes) exhibited increased sensitivity to both IFN-alpha and IFN-beta.
  • The copy number of chromosome 21q (containing interferon receptor genes) did not demonstrate a significant influence on interferon sensitivity.
  • A positive correlation was observed between the dosage of interferon genes and cellular response to interferons.

Conclusions:

  • The number of interferon genes on chromosome 9 is a key determinant of melanoma cell sensitivity to IFN-alpha and IFN-beta.
  • Interferon receptor gene dosage on chromosome 21 appears to be a less critical factor in this context.
  • These findings suggest potential for gene-targeted therapies to enhance interferon efficacy in melanoma treatment.

More Related Videos

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth06:35

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth

Published on: December 22, 2020

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...